Table 3.
Adverse effect | Patient (n) | Time of occurrence (weeks) | Outcome |
---|---|---|---|
Neurological adverse events | |||
Unconsciousness | 0 | 0 | |
Dizziness | 0 | 0 | |
Headache | 2 | 1 | Improved after treatment |
Neck stiffness | 0 | 0 | |
Nausea and vomiting | 2 | 1 | Improved after treatment |
Hypotension | 1 | 1 | Improved after treatment |
Motor dysfunction | 0 | 0 | |
Sensory dysfunction | 0 | 0 | |
Sphincter dysfunction | 0 | 0 | |
Seizures | 0 | 0 | |
Vertigo | 0 | 0 | |
Visual impairment | 0 | 0 | |
Allergic reactions | |||
Fever | 0 | 0 | |
Apnea | 0 | 0 | |
Dyspnea | 0 | 0 | |
Anaphylaxis | 0 | 0 | |
Urticaria | 0 | 0 | |
Erythema | 0 | 0 | |
Flashing | 0 | 0 | |
Local adverse events | |||
Phlebitis | 0 | 0 | |
Infection | 0 | 0 | |
Hematoma | 0 | 0 | |
Other adverse events | |||
Diarrhea | 0 | 0 | |
Constipation | 0 | 0 | |
Bronchitis | 0 | 0 | |
Pneumonia | 0 | 0 | |
Pulmonary emboli | 0 | 0 | |
Respiratory failure | 0 | 0 | |
Arrhythmia | 0 | 0 | |